190 related articles for article (PubMed ID: 28492605)
1. Severe refractory atopic dermatitis with elevated serum IgE treated with omalizumab.
Switlyk SA; Taylor AL; Gaertner EM
Cutis; 2017 Apr; 99(4):E6-E8. PubMed ID: 28492605
[No Abstract] [Full Text] [Related]
2. Omalizumab treatment in severe adult atopic dermatitis.
Thaiwat S; Sangasapaviliya A
Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.
Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP
Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516
[No Abstract] [Full Text] [Related]
4. Atopic dermatitis is an important comorbidity in severe asthma.
Lee JK; Han D
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
[No Abstract] [Full Text] [Related]
5. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Zink A; Gensbaur A; Zirbs M; Seifert F; Suarez IL; Mourantchanian V; Weidinger S; Mempel M; Ring J; Ollert M
Acta Derm Venereol; 2016 Jan; 96(1):72-6. PubMed ID: 26059424
[TBL] [Abstract][Full Text] [Related]
6. Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: two case reports and a literature review.
Nečas M; Vašků V; Březinová E
Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):89-92. PubMed ID: 31233174
[TBL] [Abstract][Full Text] [Related]
7. [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].
Schmitt J; Schäkel K
Hautarzt; 2007 Feb; 58(2):128, 130-2. PubMed ID: 17237929
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report.
Sirufo MM; De Martinis M; Ginaldi L
Medicine (Baltimore); 2018 Jun; 97(24):e10897. PubMed ID: 29901580
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
11. Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease.
Arasu A; Sharma N; Yazdabadi A; Sladden M
Australas J Dermatol; 2022 Feb; 63(1):110-111. PubMed ID: 34755893
[No Abstract] [Full Text] [Related]
12. Atopic dermatitis or hyper-IgE syndrome?
Ohameje NU; Loveless JW; Saini SS
Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
[TBL] [Abstract][Full Text] [Related]
13. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
Amrol D
South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
[TBL] [Abstract][Full Text] [Related]
14. Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker.
Huang TH; Chen YC; Lin SY; Chiu SH; Yang TT; Chiu LW; Chen YY; Lan CE
Eur J Dermatol; 2019 Dec; 29(6):658-659. PubMed ID: 31903962
[No Abstract] [Full Text] [Related]
15. Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis.
Beck LA; Saini S
J Am Acad Dermatol; 2006 Sep; 55(3):540-1; author reply 541-2. PubMed ID: 16908373
[No Abstract] [Full Text] [Related]
16. Omalizumab for patients with severe and therapy-refractory atopic eczema?
Andres C; Belloni B; Mempel M; Ring J
Curr Allergy Asthma Rep; 2008 May; 8(3):179-80. PubMed ID: 18589835
[No Abstract] [Full Text] [Related]
17. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab for treatment of refractory severe atopic dermatitis. A pediatric perspective.
Iannelli M; Caminiti L; Vaccaro M; Marafioti I; Spinuzza A; Panasiti I; Barbalace A; Crisafulli G; Pajno GB
Dermatol Ther; 2020 Jul; 33(4):e13519. PubMed ID: 32378300
[TBL] [Abstract][Full Text] [Related]
19. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines.
Hotze M; Baurecht H; Rodríguez E; Chapman-Rothe N; Ollert M; Fölster-Holst R; Adamski J; Illig T; Ring J; Weidinger S
Allergy; 2014 Jan; 69(1):132-5. PubMed ID: 24111531
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.
Ramírez del Pozo ME; Contreras Contreras E; López Tiro J; Gómez Vera J
J Investig Allergol Clin Immunol; 2011; 21(5):416-7. PubMed ID: 21905512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
